L. J. Dooren
- Immunology top 10%
- Hematology top 5%
- Molecular Biology
- Epidemiology
- Oncology
- Co-authors
- J. de KoningD. W. van BekkumJaak M. VossenJ. J. van RoodDicke KaJ RádlHenk van den BergJ. Hermans
- Topics
- Immunodeficiency and Autoimmune Disorders (7 papers)Immune Response and Inflammation (5 papers)Hematopoietic Stem Cell Transplantation (5 papers)
- Cited by
- HematologyImmunologyTransplantation
- Partner nations
- NetherlandsSwitzerlandNorth Macedonia
In The Last Decade
L. J. Dooren
23 papers receiving 477 citations
Peers
Comparison fields: 5 of 76
- Immunology 296
- Hematology 259
- Molecular Biology 107
- Epidemiology 104
- Oncology 81
Countries citing papers authored by L. J. Dooren
This map shows the geographic impact of L. J. Dooren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. J. Dooren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. J. Dooren more than expected).
Fields of papers citing papers by L. J. Dooren
This network shows the impact of papers produced by L. J. Dooren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. J. Dooren. The network helps show where L. J. Dooren may publish in the future.
Co-authorship network of co-authors of L. J. Dooren
This figure shows the co-authorship network connecting the top 25 collaborators of L. J. Dooren. A scholar is included among the top collaborators of L. J. Dooren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. J. Dooren. L. J. Dooren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 9 | |
| 3 | 107 | |
| 4 | 8 | |
| 5 | 2 | |
| 6 | 32 | |
| 7 | [Hyper-IgE syndrome]. | 1 |
| 8 | Bone marrow transplantation in man. Analysis of T and B cell functions in PWM driven Ig production. | 1 |
| 9 | 93 | |
| 10 | 27 | |
| 11 | Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study. | 6 |
| 12 | 5 | |
| 13 | 1 | |
| 14 | 4 | |
| 15 | 13 | |
| 16 | 7 | |
| 17 | 154 | |
| 18 | 2 | |
| 19 | 3 | |
| 20 | 3 |
About L. J. Dooren
L. J. Dooren is a scholar working on Immunology, Hematology and Clinical Biochemistry, having authored 24 papers that have together received 566 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (7 papers), Immune Response and Inflammation (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). The work is most often cited by research in Hematology (259 citations), Immunology (296 citations) and Transplantation (17 citations). L. J. Dooren has collaborated with scholars based in Netherlands, Switzerland and North Macedonia. Frequent co-authors include J. de Koning, D. W. van Bekkum, Jaak M. Vossen, J. J. van Rood, Dicke Ka, J Rádl, Henk van den Berg, J. Hermans, Peter J. Heidt and E.J.A. Gerritsen. Their work appears in journals such as The Lancet, The Journal of Immunology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.